Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
British Journal of Haematology
|
June 6, 2024
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regime
Joshua Bomsztyk, Sriram Ravichandran, Jahanzaib Khwaja, et al.
Haematologica
|
January 11, 2024
Limited utility of Mayo 2012 cardiac staging system for risk stratification of patients with advanced cardiac AL amyloidosis - analysis of a uniformly treated cohort of 1,275 patients
Jahanzaib Khwaja, Sriram Ravichandran, Joshua Bomsztyk, et al.
European Journal of Haematology
|
January 18, 2021
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK
Faye A Sharpley, Richa Manwani, Aviva Petrie, et al.
Blood Cancer Journal
|
August 18, 2022
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group
Andrea Havasi, Cihan Heybeli, Nelson Leung, et al.
Blood
|
January 9, 2024
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis
Joshua Bomsztyk, Sriram Ravichandran, Hannah V Giles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2022
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis
Eli Muchtar, Angela Dispenzieri, Brendan Wisniowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System
Jahanzaib Khwaja, Amy A Kirkwood, Paolo Milani, et al.
JAMA Oncology
|
August 1, 2024
Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis
Eli Muchtar, Brendan Wisniowski, Susan Geyer, et al.
JAMA Cardiology
|
August 21, 2024
Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis
Aldostefano Porcari, Ambra Masi, Ana Martinez-Naharro, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
British Journal of Haematology
|
June 6, 2024
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regime
Joshua Bomsztyk, Sriram Ravichandran, Jahanzaib Khwaja, et al.
Haematologica
|
January 11, 2024
Limited utility of Mayo 2012 cardiac staging system for risk stratification of patients with advanced cardiac AL amyloidosis - analysis of a uniformly treated cohort of 1,275 patients
Jahanzaib Khwaja, Sriram Ravichandran, Joshua Bomsztyk, et al.
European Journal of Haematology
|
January 18, 2021
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK
Faye A Sharpley, Richa Manwani, Aviva Petrie, et al.
Blood Cancer Journal
|
August 18, 2022
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group
Andrea Havasi, Cihan Heybeli, Nelson Leung, et al.
Blood
|
January 9, 2024
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis
Joshua Bomsztyk, Sriram Ravichandran, Hannah V Giles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2022
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis
Eli Muchtar, Angela Dispenzieri, Brendan Wisniowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System
Jahanzaib Khwaja, Amy A Kirkwood, Paolo Milani, et al.
JAMA Oncology
|
August 1, 2024
Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis
Eli Muchtar, Brendan Wisniowski, Susan Geyer, et al.
JAMA Cardiology
|
August 21, 2024
Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis
Aldostefano Porcari, Ambra Masi, Ana Martinez-Naharro, et al.
Page
of 2